医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Asia’s LARGEST Bio Event Coming Back with a Larger Scale! “BIOtech 2013 in Japan”

2013年03月07日 AM12:10
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

Asia’s largest bio event held annually in Tokyo: “BIOtech 2013 in Japan” will take place from May 8th to 10th, further expanding its scale from the previous time. As represented by the Novel prize winner Dr. Yamanaka’s iPS Cells Research, the Japanese & Asian bio industry is full of exciting research achievements and new business opportunities. To keep yourself updated with the latest developments and grab your chance in the fast-moving market, why not attend BIOtech 2013 Japan? Consisting of 3 pillars — [Partnering], [Conference] and [Exhibition], it gives you the best opportunity to grab the whole picture of the current and future Asian bio industry. (Photo: Business Wire)

View and Share Photo

Close Window


TOKYO

Asia’s largest bio event held annually in Tokyo: “BIOtech 2013 in Japanwill take place from May 8th to 10th, further expanding its scale from the previous time.
As represented by the Novel prize winner Dr. Yamanaka’s iPS Cells Research, the Japanese & Asian bio industry is full of exciting research achievements and new business opportunities. To keep yourself updated with the latest developments and grab your chance in the fast-moving market, why not attend BIOtech 2013 Japan?
Consisting of 3 pillars — [Partnering], [Conference] and [Exhibition], it gives you the best opportunity to grab the whole picture of the current and future Asian bio industry.

Asia's largest bio event held annually in Tokyo: "BIOtech 2013 in Japan" will take place from May 8t ...

Asia’s largest bio event held annually in Tokyo: “BIOtech 2013 in Japan” will take place from May 8th to 10th, further expanding its scale from the previous time. As represented by the Novel prize winner Dr. Yamanaka’s iPS Cells Research, the Japanese & Asian bio industry is full of exciting research achievements and new business opportunities. To keep yourself updated with the latest developments and grab your chance in the fast-moving market, why not attend BIOtech 2013 Japan? Consisting of 3 pillars — [Partnering], [Conference] and [Exhibition], it gives you the best opportunity to grab the whole picture of the current and future Asian bio industry. (Photo: Business Wire)

What is expected at the next show?
<< Partnering >> Largest number of participants ever
Through online “Bio Partnering System”, BIOtech 2013 Japan generates partnering opportunities among academics, biotech/pharmaceutical companies and others. It is sponsored by major pharmaceutical companies as below.

 

Pharma Company Sponsors (As of February 13th)

AJINOMOTO PHARMACEUTICALS

 

Astellas Pharma

AstraZeneca

Chugai Pharmaceutical

DAIICHI SANKYO

Dainippon Sumitomo Pharma

Eli Lilly Japan

F. Hoffmann-La Roche

JANSSEN PHARMACEUTICAL

KAKEN PHARMACEUTICAL

KYORIN Pharmaceutical

Meiji Seika Pharma

Mitsubishi Tanabe Pharma

MSD

NIPPON SHINYAKU

NOVARTIS PHARMA

sanofi-aventis

Takeda Pharmaceutical

 

Compared with other partnering events worldwide, Partnering at BIOtech 2013 Japan has its strength in gathering a large number of participants from the Japanese academia rich in bio/pharma-related platform technologies/seeds. You can contact and meet 200* participants from leading universities/research institutes such as RIKEN, The University of Tokyo, Kyoto University and many others, who will be presenting their latest research achievements at Academic Forum on-site. The various research themes include hot topics such as Regenerative Medicine, Cancer, Immunity/Vaccine and so on. (*expected)

<< Conference >> Total 250* presentations
The latest trends and developments on industry’s hottest topics such as iPS/ES Cell Research, Antibody Drug, Immunity, Companion Diagnostics, Plant Genomics, etc., will be addressed by industry leaders and academic presenters in total 250* presentations. (*expected)
Below are excerpts from Keynote/Special Sessions.

Normal and Neoplastic Stem Cells
Irving Weissman, Professor, Pathology, Developmental Biology Director, Institute for Stem Cell Biology & Regenerative Medicine, Stanford University
Exploring Personalized Healthcare (PHC) Innovative Approaches in Neuroscience Drug Discovery
Emilio Merlo Pich, Head, Clinical Imaging, Neuroscience DTA pRED, F. Hoffmann-La Roche Ltd.
iPS Technology and its Potential for Future Medicine
Hiro Nakauchi, Professor and Director, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo

<< Exhibition >> Almost all the major companies exhibit here
This year, the exhibition will expand its scale to 600* exhibitors, gathering leading companies from around the world as below and may others; (*expected)

 

Excerpts from Exhibitors 2013

AFFYMETRIX JAPAN

 

AGILENT TECHNOLOGIES JAPAN

AJINOMOTO

ANTI CANCER

ASAHI GLASS

BOEHRINGER INGELHEIM

CATALENT PHARMA

DSM

EPPENDORF

EUROPEAN PATENT OFFICE

FUJIFILM DIOSYNTH BIOTECHNOLOGIES

ILLUMINA

KAWASAKI HEAVY INDUSTRIES

METTLERTOLEDO

MSD

OLYMPUS BIOTECH

PATHEON

SANDOZ

SANOFI

SARSTEDT

SRI INTERNATIONAL

VEOLIA WATER SOLUTIONS & TECHNOLOGIES

 

Furthermore, more novel products/technologies by venture/start-up companies are expected this year, due to the newly-launched “Table-top Exhibiting Area”. Another new zone is “Clinical & Diagnostics Zone”, which features the essential field especially for personalized medicine.
Becoming larger and more extensive, Exhibition at BIOtech 2013 Japan will enhance its value as Asia’s largest product/technology showcase. >> Access “e-Guidebookto search exhibitors.

**To get the latest information on BIOtech 2013 Japan, register yourself as a visitor. (FREE Invitation Ticket Request)

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130306005579/en/

CONTACT

BIOtech 2013 in Japan Show Management,
Reed Exhibitions Japan Ltd.
Kyoko
Nagakusa, +81-3-3349-8518
visitor-eng.bio@reedexpo.co.jp
www.bio-t.jp/en/

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Orthocell Granted European Tendon Regeneration Patent
  • Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing
  • 三叶草生物制药完成6,280万元人民币A轮融资
  • Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.
  • Walmart, JD.com, IBM and Tsinghua University Launch a Blockchain Food Safety Alliance in China